Advantage
The company has obtained 1 new drug certificate, 14 drug registration approval documents issued by the national Bureau, 17 authorized patents. At present, we have completed nearly 20 domestic r&d applications and maintained a good pass rate. The company has the practical experience of DMF registration, PAI inspection and successful application for EU CEP certificate in the United States, and can provide authoritative regulations and technical information requirements for drug r&d registration.
